GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aurisco Pharmaceutical Co Ltd (SHSE:605116) » Definitions » Gross-Profit-to-Asset %

Aurisco Pharmaceutical Co (SHSE:605116) Gross-Profit-to-Asset % : 26.47% (As of Sep. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Aurisco Pharmaceutical Co Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Aurisco Pharmaceutical Co's annualized Gross Profit for the quarter that ended in Sep. 2024 was ¥868 Mil. Aurisco Pharmaceutical Co's average Total Assets over the quarter that ended in Sep. 2024 was ¥3,280 Mil. Therefore, Aurisco Pharmaceutical Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Sep. 2024 was 26.47%.


Aurisco Pharmaceutical Co Gross-Profit-to-Asset % Historical Data

The historical data trend for Aurisco Pharmaceutical Co's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aurisco Pharmaceutical Co Gross-Profit-to-Asset % Chart

Aurisco Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross-Profit-to-Asset %
Get a 7-Day Free Trial 29.53 25.80 24.19 27.70 30.63

Aurisco Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 42.21 31.20 27.39 34.04 26.47

Competitive Comparison of Aurisco Pharmaceutical Co's Gross-Profit-to-Asset %

For the Biotechnology subindustry, Aurisco Pharmaceutical Co's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aurisco Pharmaceutical Co's Gross-Profit-to-Asset % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Aurisco Pharmaceutical Co's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Aurisco Pharmaceutical Co's Gross-Profit-to-Asset % falls into.



Aurisco Pharmaceutical Co Gross-Profit-to-Asset % Calculation

Aurisco Pharmaceutical Co's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=705.973/( (2035.304+2574.611)/ 2 )
=705.973/2304.9575
=30.63 %

Aurisco Pharmaceutical Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Sep. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Sep. 2024 )/( (Total Assets (Q: Jun. 2024 )+Total Assets (Q: Sep. 2024 ))/ count )
=868.144/( (2869.495+3690.916)/ 2 )
=868.144/3280.2055
=26.47 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Sep. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Aurisco Pharmaceutical Co Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Aurisco Pharmaceutical Co's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Aurisco Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
Badu Industrial Park, Tiantai County, Zhejiang Province, Taizhou, CHN, 317200
Aurisco Pharmaceutical Co Ltd is engaged in production and sales of specialty APIs and pharmaceutical intermediates. The company's products include API's and Intermediates. Its products are supplied to Asia, Europe, America and Middle East through a well-established sales network.
Executives
Qiu Pei Jing Director
Zhao Zhen Ping senior management
Zhang Li Qin senior management

Aurisco Pharmaceutical Co Headlines

No Headlines